Alpha 2.0
Login Register
» Authors » Willem Boer

Willem Boer

Explore the profile of Willem Boer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 655
Followers 0
Related Specialties
Critical Care
Emergency Medicine
Nephrology
Top 10 Co-Authors
Patrick M Honore
Olivier Joannes-Boyau
Cathy De Deyne
Frank Jans
Herbert D Spapen
Jo Dens
Rita Jacobs
Cornelia Genbrugge
Elisabeth De Waele
Ward Eertmans
Published In
Crit Care
Ann Intensive Care
Intensive Care Med
Resuscitation
Blood Purif
Affiliations
Soon will be listed here.
Recent Articles
1.
The effects of differing anticoagulant regimes on blood quality after cell salvage in coronary artery bypass grafting (CABG): a pilot study
Boer W, van Tornout M, Brusseleers M, Strauven M, de Vooght P, Vander Laenen M, et al.
J Cardiothorac Surg . 2023 Apr; 18(1):116. PMID: 37031168
Background: Cell salvage reduces allogenic blood transfusion requirements in surgery. We present a pilot study exploring the impact of anticoagulant choice, citrate or heparin, on the quality of cell salvaged...
2.
Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
Boer W, Verbrugghe W, Hoste E, Jacobs R, Jorens P
Ann Intensive Care . 2023 Mar; 13(1):16. PMID: 36899104
The use of citrate, through reversible binding of calcium, has become the preferred choice for anticoagulation in continuous renal replacement therapy in the critically ill patient. Though generally considered as...
3.
Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium
Schaubroeck H, Vandenberghe W, Boer W, Boonen E, DeWulf B, Bourgeois C, et al.
Crit Care . 2022 Jul; 26(1):225. PMID: 35879765
Background: Acute kidney injury (AKI) has been reported as a frequent complication of critical COVID-19. We aimed to evaluate the occurrence of AKI and use of kidney replacement therapy (KRT)...
4.
Stand Alone Renal Doppler to Assess the Risk of Acute Kidney Injury Is Dead: Maybe It Is Time to Consider a Triumvirate?
Honore P, Redant S, Boer W
Crit Care Med . 2022 Mar; 50(4):719-721. PMID: 35311785
No abstract available.
5.
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
Honore P, Redant S, Preseau T, Moorthamers S, Kaefer K, Barreto Gutierrez L, et al.
Crit Care . 2022 Jan; 26(1):15. PMID: 34996512
No abstract available.
6.
Citrate dose for continuous hemofiltration: effect on calcium and magnesium balance, parathormone and vitamin D status, a randomized controlled trial
Boer W, Fivez T, Vander Laenen M, Bruckers L, Gron H, Schetz M, et al.
BMC Nephrol . 2021 Dec; 22(1):409. PMID: 34895160
Background: Regional citrate anticoagulation may cause a negative calcium balance, systemic hypocalcemia and parathormone (PTH) activation but randomzed studies are not available. Aim was to determine the effect of citrate...
7.
Catheter Port Reversal in Citrate Continuous Veno-Venous Hemofiltration
Boer W, van Tornout M, Vander Laenen M, Engelen K, Meex I, Jorens P
Kidney Int Rep . 2021 Nov; 6(11):2775-2781. PMID: 34805629
Introduction: Knowledge of effects of catheter port reversal (CathPR), when blood is withdrawn from the venous port and returned via the arterial port, often used in dysfunctional catheters in renal...
8.
Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
Honore P, Redant S, Preseau T, Moorthamers S, Kaefer K, Barreto Gutierrez L, et al.
Crit Care . 2021 Nov; 25(1):379. PMID: 34724963
No abstract available.
9.
What should clinicians know about the renal effect and the mechanism of action of levosimendan?
Honore P, Redant S, Moorthamers S, Preseau T, Kaefer K, Barreto Gutierrez L, et al.
Expert Opin Drug Saf . 2021 Oct; 20(12):1459-1461. PMID: 34612116
No abstract available.
10.
Fluid management in diabetic ketoacidosis: new tricks for old dogs?
Besen B, Boer W, Honore P
Intensive Care Med . 2021 Oct; 47(11):1312-1314. PMID: 34608527
No abstract available.